2 December 2021 - To 28 November 2021, the TGA has received 354 reports which have been assessed as likely to be myocarditis from about 24.4 million doses of Comirnaty (Pfizer).
Two new cases of thrombosis with thrombocytopenia syndrome were reported this week, taking the total to 166 cases from about 13.5 million doses of Vaxzevria (AstraZeneca).